The global intraoperative neuromonitoring market is expected to register significant growth in the forecoming years. Major factors driving growth of the global target markets are, rising health care expenditure and increasing prevalence and incidences of life threating disease such as cancer, diabetes, etc. across the globe. In addition, growing population, government initiatives, favorable reimbursement policies are the other factors expected to drive the growth of the target market over the forecast period.
The global intraoperative neuromonitoring market report has been segmented on the basis source type, application, modality, end user, and region.
On the basis of source type, the global market has been segmented into insourced monitoring and outsourced monitoring.
On the basis of wound type, the global intraoperative neuromonitoring market has been segmented into acute wound and chronic wound.
On the basis of application, the global market has been segmented into spinal surgery, neurosurgery, vascular surgery, ENT surgery, orthopedic surgery, and other surgeries.
On the basis of modality, the global market has been segmented into Motor Evoked Potentials (MEPs), Somatosensory Evoked Potentials (SSEPs), Electroencephalography (EEG), Electromyography (EMG), Brainstem Auditory Evoked Potentials (BAEPs), and Visual Evoked Potentials (VEPs).
On the basis of end users, the global market has been segmented into Hospitals & Clinics and Ambulatory Surgical Centers (ASCs)
On the basis of region, the global markets segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Request For The Sample Report Here: https://marketresearch.biz/report/intraoperative-neuromonitoring-market/request-sample/
In 2018, North America intraoperative neuromonitoring market is expected to account for major share in the global market in terms of revenue, and is expected to maintain its dominance over the forecast period, due to developed medical facilities, rising health care expenditure, favorable reimbursement policies in country in the region. However, Asia Pacific intraoperative neuromonitoring market is projected to register highest CAGR in the next five years, due to increased health awareness among consumers and rising surgical procedures in countries in the region.
Key players operating in the global intraoperative neuromonitoring market includes Smith & Nephew plc, NuVasive, Inc., Computational Diagnostics, Inc., Natus Medical Incorporated, IntraNerve, LLC, inomed Medizintechnik GmbH, Accurate Monitoring LLC, Nihon Kohden Corporation, Moberg Research, Inc., and Argos Neuromonitoring LP.